Quantum Materials as a Platform for Next-Gen Biomedical Applications
Wednesday, Feb. 11, 2026
5:00pm to 7:00pm
11
This presentation will showcase AQM’s product capabilities and highlight how silicon quantum dots can power new solutions in diagnostics, biosensing, bioimaging and cosmetic applications.
Quantum Materials as a Platform for Next-Gen Biomedical Applications
Applied Quantum Materials (AQM) is a world leader in silicon nanomaterials for a broad range of applications in nanoelectronics, sensing, energy, displays, security and bio-diagnostics. At AQM, we develop a scalable, high-performance platform that accelerates biomaterials and life-science innovation. By engineering silicon quantum dots with surface chemistries and biomolecules at the nanoscale, AQM enables differentiated functionality, reliable manufacturability, and smoother translation from R&D to real-world products.
Dr. David Antoniuk
Dr. Antoniuk holds a Ph.D. in Engineering Physics from the University of Alberta and brings 30 years of business development, product marketing and executive management experience. David has extensive experience in technology commercialization and building strategic business relationships. Prior to forming AQM, he was Director of Business Development for TRLabs, Canada’s largest IT consortium; and Director, Nanotechnology where he formulated the strategy for creating a nanotechnology initiative for the Government of Alberta. David has co-founded several technology start-ups. He was President of the nanoAlberta Cluster Association.
Dr. Dorra Gargouri
Dorra joined AQM in February 2024. She received an M.Sc. in Molecular Chemistry from Paris IV-Sorbonne University in 2015 and completed her Ph.D. in Bio-organic Chemistry from Normandie University Rouen, France, in 2020. Her Ph.D. project research was focused on the development of a new biosensor for mycotoxins detection and synthesis of multifunctional reagents.
Prior to her role at AQM, Dr. Gargouri worked as a postdoctoral researcher at Commissariat à l'énergie atomique et aux énergies alternatives in Saclay, France. Her work there focused on developing innovative and sustainable nanomaterials, increasing their complexity to evaluate their cytotoxicity for industry applications. Following this, she moved to Canada, where she joined the Lipids/Materials chemistry research group at the University of Alberta as a postdoctoral researcher, contributing to the modification of siRNA with different fatty acids for gene silencing.
Applied Quantum Materials Inc.
Applied Quantum Materials Inc. is an innovator and leader in Group 14-based nanomaterials. AQM designs, develops and manufactures silicon, carbon and germanium nanomaterials, as well as, their chemical precursors to serve advanced technology markets through a client focused approach.
8101 Gateway Blvd NW
Edmonton, AB, T6E 3X8